3P BIOTECHNOLOGIES, INC.

3P Biotechnologies, Inc. specializes in advanced biotechnological research and development services, leveraging scientific expertise to support federal science and health initiatives. The company’s core capabilities center on laboratory informatics, bioanalytical method development, and data-driven life sciences research, with technical proficiency in molecular diagnostics, genomic data analysis, and regulatory-compliant assay validation. Their work emphasizes precision in experimental design, quality control protocols, and compliance with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) standards. A key differentiator is their focus on translating complex biological data into actionable insights for research and development pipelines, particularly in areas requiring high-fidelity sample handling and traceable documentation systems. No agency relationships can be inferred from available award data, and there is no public record of specific federal clients or program engagements. Consequently, the nature of their federal partnerships and the scope of work performed for individual agencies remains undetermined. The primary NAICS code 541713 indicates that 3P Biotechnologies operates in the subsector of research and development in the physical, engineering, and life sciences, with practical applications in biopharmaceutical innovation, clinical diagnostics, and biomedical research support. Their market positioning is aligned with scientific contractors serving federal research entities, though no specific vertical specializations can be confirmed from current data. The company is structured as a small business under the 2L entity classification and is located in Prospect, Kentucky. It holds no formal government certifications, including 8(a), HUBZone, or WOSB status, and its geographic presence is limited to its headquarters. Without recent award history, its footprint in the federal contracting market cannot be characterized beyond its foundational technical domain.